Deriving actionable strategies to enhance cancer immunotherapy response

Project: Research

Search results

  • 2022

    Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation

    Wang, M., Zadeh, S., Pizzolla, A., Thia, K., Gyorki, D. E., McArthur, G. A., Scolyer, R. A., Long, G., Wilmott, J. S., Andrews, M. C., Au-Yeung, G., Weppler, A., Sandhu, S., Trapani, J. A., Davis, M. J. & Neeson, P. J., Apr 2022, In: Journal for ImmunoTherapy of Cancer. 10, 4, 16 p., e004095.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    12 Citations (Scopus)
  • Multi-modal molecular programs regulate melanoma cell state

    Andrews, M. C., Oba, J., Wu, C. J., Zhu, H., Karpinets, T., Creasy, C. A., Forget, M. A., Yu, X., Song, X., Mao, X., Robertson, A. G., Romano, G., Li, P., Burton, E. M., Lu, Y., Sloane, R. S., Wani, K. M., Rai, K., Lazar, A. J., Haydu, L. E., & 16 othersBustos, M. A., Shen, J., Chen, Y., Morgan, M. B., Wargo, J. A., Kwong, L. N., Haymaker, C. L., Grimm, E. A., Hwu, P., Hoon, D. S. B., Zhang, J., Gershenwald, J. E., Davies, M. A., Futreal, P. A., Bernatchez, C. & Woodman, S. E., Dec 2022, In: Nature Communications. 13, 1, 18 p., 4000.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    12 Citations (Scopus)
  • 2021

    Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    Andrews, M. C., Duong, C. P. M., Gopalakrishnan, V., Iebba, V., Chen, W. S., Derosa, L., Khan, M. A. W., Cogdill, A. P., White, M. G., Wong, M. C., Ferrere, G., Fluckiger, A., Roberti, M. P., Opolon, P., Alou, M. T., Yonekura, S., Roh, W., Spencer, C. N., Curbelo, I. F., Vence, L., & 51 othersReuben, A., Johnson, S., Arora, R., Morad, G., Lastrapes, M., Baruch, E. N., Little, L., Gumbs, C., Cooper, Z. A., Prieto, P. A., Wani, K., Lazar, A. J., Tetzlaff, M. T., Hudgens, C. W., Callahan, M. K., Adamow, M., Postow, M. A., Ariyan, C. E., Gaudreau, P. O., Nezi, L., Raoult, D., Mihalcioiu, C., Elkrief, A., Pezo, R. C., Haydu, L. E., Simon, J. M., Tawbi, H. A., McQuade, J., Hwu, P., Hwu, W. J., Amaria, R. N., Burton, E. M., Woodman, S. E., Watowich, S., Diab, A., Patel, S. P., Glitza, I. C., Wong, M. K., Zhao, L., Zhang, J., Ajami, N. J., Petrosino, J., Jenq, R. R., Davies, M. A., Gershenwald, J. E., Futreal, P. A., Sharma, P., Allison, J. P., Routy, B., Zitvogel, L. & Wargo, J. A., Aug 2021, In: Nature Medicine. 27, 8, p. 1432–1441 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

    275 Citations (Scopus)
  • Identification of microrna–mrna networks in melanoma and their association with pd-1 checkpoint blockade outcomes

    Szczepaniak Sloane, R. A., White, M. G., Witt, R. G., Banerjee, A., Davies, M. A., Han, G., Burton, E., Ajami, N., Simon, J. M., Bernatchez, C., Haydu, L. E., Tawbi, H. A., Gershenwald, J. E., Keung, E., Ross, M., McQuade, J., Amaria, R. N., Wani, K., Lazar, A. J., Woodman, S. E., & 3 othersWang, L., Andrews, M. C. & Wargo, J. A., 1 Nov 2021, In: Cancers. 13, 21, 15 p., 5301.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    8 Citations (Scopus)
  • Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma

    White, M. G., Szczepaniak Sloane, R., Witt, R. G., Reuben, A., Gaudreau, P. O., Andrews, M. C., Feng, N., Johnson, S., Class, C. A., Bristow, C., Wani, K., Hudgens, C., Nezi, L., Manzo, T., De Macedo, M. P., Hu, J., Davis, R., Jiang, H., Prieto, P., Burton, E., & 12 othersHwu, P., Tawbi, H., Gershenwald, J., Lazar, A. J., Tetzlaff, M. T., Overwijk, W., Woodman, S. E., Cooper, Z. A., Marszalek, J. R., Davies, M. A., Heffernan, T. P. & Wargo, J. A., 2021, In: OncoImmunology. 10, 1, 12 p., 1992880.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    9 Citations (Scopus)